Infusion Center of NJ

The Infusion Center of NJ, located in Clifton, New Jersey, operates under the medical direction of Dr. Jeffrey A. Weiss, MD, FACP, a board-certified internist with Fellowship credentials from the American College of Physicians. The practice integrates concierge medicine principles with regenerative therapies, providing patients in the northern New Jersey region access to peptide protocols, intravenous nutrient therapy, and aesthetic treatments within a single clinical setting. Dr. Weiss structures patient care around extended consultation times and direct provider access, distinguishing the practice from volume-based medical models common in the Clifton area.

Peptide therapy at the Infusion Center of NJ includes BPC-157, a synthetic peptide derived from body protection compound research, administered for soft tissue repair, gastrointestinal healing, and inflammatory conditions affecting joints and tendons. The clinic also offers Tirzepatide, a dual GIP/GLP-1 receptor agonist peptide used in medical weight management programs that combine metabolic optimization with body composition goals. These peptides are prescribed following comprehensive laboratory evaluation and tailored to individual patient physiology, with dosing protocols adjusted based on response markers and clinical progress. The practice does not employ one-size-fits-all peptide regimens, instead requiring baseline metabolic panels, inflammatory markers, and patient-specific health histories before initiating treatment.

Dr. Weiss applies his internal medicine background to peptide therapy by evaluating how these treatments interact with existing medications, chronic conditions, and age-related physiological changes. His FACP designation reflects advanced training in adult medicine, which informs his approach to patients managing multiple health concerns simultaneously. The clinic's integrative model means peptide protocols often run concurrent with IV micronutrient therapy designed to address deficiencies that may limit peptide efficacy, such as amino acid availability for tissue repair or B-vitamin status affecting metabolic pathways. This coordinated approach requires patients to engage in ongoing monitoring rather than isolated treatment episodes.

Patients at the Infusion Center of NJ receive in-person consultations at the Clifton facility, where initial visits typically involve detailed medical history review, physical examination, and discussion of treatment objectives with measurable endpoints. The practice does not offer telehealth peptide prescribing, requiring all patients to establish care through face-to-face evaluation. Follow-up protocols include scheduled reassessments to track biomarkers, adjust peptide dosing, and determine treatment duration based on clinical response rather than predetermined timelines. The concierge structure allows for same-week appointment availability and direct communication with Dr. Weiss between scheduled visits, which proves relevant for patients experiencing dose-related effects or requiring protocol modifications.

The clinic's 4.8-star rating across 77 Google reviews reflects patient feedback on appointment accessibility, wait times, and treatment coordination, though individual results with peptide therapy vary based on patient compliance, baseline health status, and condition complexity. The Infusion Center of NJ serves patients throughout Passaic County and surrounding northern New Jersey communities, with the Clifton location providing access to regenerative medicine options without requiring travel to New York City or Philadelphia metropolitan areas. The practice accepts concierge membership arrangements that cover extended consultations and care coordination, with peptide therapy costs and laboratory monitoring billed separately based on specific protocols prescribed.